HealthLatest

Casgevy: UK approves gene-editing drug for blood disorders


Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button